nderstanding Circadian Abnormalities in Cardiovascular Diseases and Circadian Regulation of Cardiac Medicines

IIT hyderabad0 个研究点目标入组 0 人开始时间: 待定最近更新: 2024年3月4日

试验速览

暂无简介。

•1. Adults of either gender ( <40 years young group, >40 years older group) suffering from
•cardiovascular diseases (a narrow age range to avoid age-related circadian variations)
•2. Cardiovascular disease diagnosed based on the clinical manifestations and confirmed
•through an electrocardiogram (ECG)
•3. Age and gender (and occupation, if possible) matched healthy participants as control
•subjects based on medical history, clinical examination, and laboratory investigations
•4. Subjects (patients and controls) willing to provide written informed consent and comply
•with protocol requirements

•1. Subjects reluctant to provide written informed consent or to comply with the study
•2. Subjects with any significant medical history (ongoing or in the recent past)
•3. Currently diagnosed with a neurological or sleep disorder (narcolepsy, obstructive sleep
•apnea, restless leg syndrome) and/or being prescribed a non-psychotropic medication that
•can alter sleep and circadian rhythms (such as cortisone)
•4. Subjects with severe anemia (Hb level < 7g/dL)
•5. Female patients who are pregnant at the time of enrolment
•6. Subjects who are chronic alcoholics or smokers

发起方